Paper3279
Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.
Barbeau A and 2 others. Can Med Assoc J, 1976. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease. Papers, record 3279. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3279
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MSH Release-Inhibiting Hormone | Major topic |
| Parkinson Disease | Major topic |
| Adult | |
| Aged | |
| Dose-Response Relationship, Drug | |
| Drug Administration Schedule | |
| Drug Evaluation | |
| Female | |
| Humans | |
| Middle Aged | |
| Motor Skills |
Source PubMed
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 238221 | Intensification of central catecholaminergin and serotonergic processes by the hypothalamic factors MIF and TRF and by angiotensin II. | Pharmacol Biochem Behav | 1975 | https://conductscience.org/library/papers/238221 | PubMed |
| 2 | 4364044 | Action of two hypothalamic factors (TRH, MIF) and of angiotensin II on the behavioral effects of L-DOPA and 5-hydroxytryptophan in mice. | Pharmacol Biochem Behav | 1974 | https://conductscience.org/library/papers/4364044 | PubMed |
| 3 | 4633626 | Deserpidine antagonism by a tripeptide, L-prolyl-L-leucyglycinamide. | Neuroendocrinology | 1973 | https://conductscience.org/library/papers/4633626 | PubMed |
| 4 | 4858836 | DOPA potentiation in ablated animals and brain levels of biogenic amines in intact animals after prolyl-leucylglycinamide. | Neuroendocrinology | 1974 | https://conductscience.org/library/papers/4858836 | PubMed |
| 5 | 5820999 | Treatment of parkinsonism with levodopa. | Arch Neurol | 1969 | https://conductscience.org/library/papers/5820999 | PubMed |
| 6 | 4125041 | M.I.F.: effect on levodopa dyskinesias in man. | Lancet | 1973 | https://conductscience.org/library/papers/4125041 | PubMed |
| 7 | 4140382 | Letter: Lithium and M.R.I.H. in tardive dyskinesia. | Lancet | 1974 | https://conductscience.org/library/papers/4140382 | PubMed |
| 8 | 4216256 | Melanocyte-stimulating hormone and the hypothalamic hormone which inhibits its release. | Adv Neurol | 1974 | https://conductscience.org/library/papers/4216256 | PubMed |
| 9 | 4398196 | Isolation and structure of hypothalamic MSH release-inhibition hormone. | Biochem Biophys Res Commun | 1971 | https://conductscience.org/library/papers/4398196 | PubMed |
| 10 | 4610443 | The disappearance, excretion, and metabolism of tritiated prolyl-leucyl-glycinamide in man. | Neuroendocrinology | 1974 | https://conductscience.org/library/papers/4610443 | PubMed |
| 11 | 4614981 | Effect of melanocyte-stimulating hormone-release inhibiting factor (MIF) in Parkinson's syndrom. | Eur Neurol | 1974 | https://conductscience.org/library/papers/4614981 | PubMed |
| 12 | 4640811 | Preliminary clinical studies with L-prolyl-L-leucyl-glycine amide in Parkinson's disease. | Can Med Assoc J | 1972 | https://conductscience.org/library/papers/4640811 | PubMed |
| 13 | 4746492 | Dopamine synthesis: stimulation by a hypothalamic factor. | Science | 1973 | https://conductscience.org/library/papers/4746492 | PubMed |
| 14 | 4837910 | Oxotremorine antagonism by prolyl-leucyl-glycine-amide administered by different routes and with several anticholinergics. | Pharmacol Biochem Behav | 1974 | https://conductscience.org/library/papers/4837910 | PubMed |
| 15 | 4947365 | DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF). | Life Sci I | 1971 | https://conductscience.org/library/papers/4947365 | PubMed |
| 16 | 5064701 | Oxotremorine antagonism by a hypothalamic hormone, melanocyte-stimulating hormone release-inhibiting factor (MIF). | Proc Soc Exp Biol Med | 1972 | https://conductscience.org/library/papers/5064701 | PubMed |
| 17 | 5283931 | Regulation of formation and proposed structure of the factor inhibiting the release of melanocyte-stimulating hormone. | Proc Natl Acad Sci U S A | 1971 | https://conductscience.org/library/papers/5283931 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38116429 | Stapling Amantadine to Melanostatin Neuropeptide: Discovery of Potent Positive Allosteric Modulators of the D2 Receptors. | ACS Med Chem Lett | 2023 | https://conductscience.org/library/papers/38116429 | PubMed |
| 18686 | On the optimal dosage of Pro-Leu-Gly-NH2 (MIF) in neuropharmacological tests and clinical use. | Naunyn Schmiedebergs Arch Pharmacol | 1977 | https://conductscience.org/library/papers/18686 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3279
GET https://conductscience.org/api/papers/v1/3279/authors